Skip to main content
Fig. 2 | Biomarker Research

Fig. 2

From: Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and response

Fig. 2

TIGS and ORR to ICI across all tumors in retrospective cohort (A) and within tumors (B). TIGS and survival across all tumors (C), melanoma (D), NSCLC (E), and RCC (F). A. Objective response rates (ORR) observed in the retrospective cohort for each TIGS group. B. ORR observed in each TIGS group for three disease types within the retrospective cohort. C-F. Survival curves for each TIGS group in the retrospective cohort (C), melanoma (D), NSCLC (E), RCC (F)

Back to article page